Clinical Trial Update: A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol [Phase 3]

View source ↗

Summary

A Phase 3 prospective trial evaluating a cytarabine-containing protocol for newly diagnosed Langerhans Cell Histiocytosis in children, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Snippet

Sponsor: Shanghai Children's Medical Center | Conditions: Langerhans Cell Histiocytosis | Phase 3 | Status: RECRUITING